PAPER CODE: 01304B
Third M.B.B.S. (Part - II) Examination, Winter - 2020 (March 2021)
MEDICINE & ALLIED SUBJECTS II
SECTION - B & SECTION - C
Instructions:
--- Content provided by FirstRanker.com ---
- Use blue/black ball point pen only.
- Do not write anything on the blank portion of the question paper. If written anything, such type of act will be considered as an attempt to resort to unfair means.
- All questions are compulsory.
- The number to the right indicates full marks.
- Draw diagrams wherever necessary.
- Distribution of syllabus in Question is only meant to cover entire syllabus within the stipulated frame. The Question paper pattern is a guideline. Questions can be asked from any papers syllabus into any question paper. Students cannot claim that the Question is out of syllabus. As it is only for the placement sake, the distribution has been done.
- Use a common answer book for Section B & C.
--- Content provided by FirstRanker.com ---
SECTION - B (21 Marks)
SECTION - B (SAQ) (21 Marks)
2. Short answer question (any three out of five): [3 x 3 = 9]
--- Content provided by FirstRanker.com ---
- Criteria for metabolic syndrome
- Pellagra
- Treatment of lepra reaction
- Treatment of scorpion sting
- Narcolepsy
--- Content provided by FirstRanker.com ---
3. Short answer question (any four out of six): [4 x 3 = 12]
- Antiphospholipid syndrome - clinical features
- Clinical features of autonomic neuropathy
- Vitamin D deficiency
- Features of schizophrenia
- C-reactive protein
- Treatment of nephrotic syndrome
--- Content provided by FirstRanker.com ---
SECTION - C (24 Marks)
SECTION - C (LAQ) (24 Marks)
4. Describe risk factors, clinical features, investigations and management of stroke (cerebrovascular accident).
--- Content provided by FirstRanker.com ---
5. Discuss etiology, pathogenesis, clinical features, investigations and treatment of community acquired pneumonia.
6. A 45 yr old woman presents with weight loss, easy fatigue, anorexia and generalised edema. Her creatinine was 8.5 mg%, calcium 6 mg% and phosphorus 7 mg%. Discuss approach, investigations and management